Join us for a Journey of Innovation at J-STAR Research, Inc.’s Cranbury Open House! 🗓 September 6th & 7th, 4 PM – 6 PM 📍 2 Clarke & 6 Cedarbrook, Cranbury, NJ Witness cutting-edge R&D and advanced manufacturing at our research and development and manufacturing facilities dedicated to crystallization, R&D, drug product R&D, and GMP […]
J-STAR Research, Inc.’s Cranbury Open House Read More »
Porton Pharma Solutions Ltd. continues to expand its reach globally. Last year, we launched the construction of a new site in Menges, Slovenia. The state-of-the-art GMP manufacturing site will significantly expand Porton’s network beyond China and the US as it sets out to provide solutions to customers and partners in Europe. Moreover, Porton also started
We’re honored to have Alexandra Pichard Nielsen, Vice President for Business Development at Porton Pharma Solutions Ltd., join us at BOS Basel 2023! We are excited to witness Alexandra’s expertise and leadership in action as she explores new opportunities, fosters partnerships, and drives business growth for Porton Pharma. Stay tuned for insightful updates on how
Join us in welcoming Dr. Wenfang Miao (Renee) as the new CEO of Porton USA, L.L.C. and J-STAR Research, Inc., and Vice-President of Porton Pharma Solutions, LTD. Dr. Miao brings with her more than 25 years of experience in technical, operational, and strategic leadership within the pharmaceutical industry as she will navigate Porton’s overall business
We are thrilled to announce the establishment of our state-of-the-art Small Molecule Platform in Shanghai, revolutionizing our CDMO services. With this exciting development, Porton Pharma Solutions Ltd. now have seven R&D and production facilities in Shanghai that are equipped to provide comprehensive solutions for drug substance, drug preparation, synthetic macromolecules, and biological macromolecules. As a trusted
Dr. Angelo Maria Manzo, our esteemed Senior Business Development Manager at Porton Pharma Solutions Ltd., joins us at BOS Basel 2023! Angelo’s deep industry knowledge and strategic vision are set to make a remarkable impact as he explores new collaborations, identifies growth opportunities, and expands our network. Drop by Stand 17 to catch up with
Join J-STAR Research, Inc. Executive Director of computational chemistry and data science, Yuriy Abramov, Ph.D., as he takes the stage as an invited speaker at the 6th David Grand Symposium on June 15. He will share his insights on computational ctudies on the crystallization development and characterization of pharmaceutical crystals, and engage in meaningful discussions
Serge Kechichian Joins Forces for a Charitable Swing at the DCAT Scholarship Golf Outing Our very own Serge Kechichian is all set to tee it up for a cause with colleagues, suppliers, and customers in support of the DCAT (Drug, Chemical & Associated Technologies Association) Scholarship golf outing. Under DCAT’s Science and Scholarship Committee’s scholarship
Serge Kechichian Joins Forces for a Charitable Swing at the DCAT Scholarship Golf Outing Read More »
J-Star Research and Porton Pharma Solutions Ltd. are excited to be exhibiting at this year’s American Association of Pharmaceutical Scientists (AAPS) Annual Meeting at the Boston Convention Center on October 16th – 19th! Stay tuned for more information regarding our Chalk Talk, attendees, and more. Attending the show? Reach out to meetings@jstar-research.com to schedule a meeting with our technical experts. Looking forward
AAPS Annual Meeting at the Boston Convention Center on October 16th – 19th Read More »
PORTON PHARMA SOLUTIONS LTD., a world leading CDMO (Hereafter PORTON) announces plans to invest into a new state of the Art cGMP/API facility inside, Life Science Park Mengeš, Slovenia currently owned and operated by Lek Pharmaceuticals d.d., part of NOVARTIS group. PORTON’s manufacturing activity in the Life Science Park Mengeš will be totally separated from the
Porton Pharma Solutions Ltd. to Expand Operations in Europe Read More »